10-Q: Encompass Health Q1 2026 Financial Results

Encompass Health reported a 9% increase in net operating revenues for Q1 2026, driven by volume growth and pricing improvements.

Summary

• Net operating revenues reached $1.586 billion, a 9.0% increase compared to Q1 2025.
• Net income attributable to Encompass Health rose to $194.5 million, up from $151.5 million in the prior year period.
• Diluted earnings per share (EPS) increased to $1.93 from $1.48 in Q1 2025.
• Adjusted EBITDA grew to $348.8 million, compared to $313.6 million in Q1 2025.
• Discharge volume increased by 4.3% year-over-year.
• The company successfully refinanced its credit agreement, extending maturity to 2031.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong performance, reflecting solid operational growth and proactive balance sheet management.

Positives

• Strong revenue growth of 9.0% year-over-year.
• Significant increase in net income and EPS.
• Successful execution of de novo hospital openings and capacity expansions.
• Disciplined capital structure with no significant debt maturities until 2028.
• Successful collection of $21.9 million related to litigation against former executives.

Negatives

• Salaries and benefits expenses increased by 7.3% to $818.1 million.
• General and administrative expenses rose 11.3% due to ERP system transition costs.
• Increased provision for income tax expense to $56.4 million.
• Ongoing regulatory and reimbursement challenges, including Review Choice Demonstration (RCD) impacts.

Risks

• High concentration in Medicare and Medicare Advantage reimbursement.
• Potential for reduced reimbursement rates or delays due to federal government shutdowns or regulatory changes.
• Staffing shortages and competitive labor market pressures increasing costs.
• Uncertainty regarding the impact of the Review Choice Demonstration (RCD) on claim collectability.
• Legal and regulatory risks, including potential qui tam lawsuits.

Future Outlook

The company remains optimistic about long-term demand driven by an aging population. It expects a net increase in Medicare payment rates of approximately 2.4% effective October 1, 2026, based on the 2027 Proposed IRF Rule. Capital expenditures for 2026 are projected between $920 million and $995 million.

Management Comments

• Management believes the company is well-positioned to adapt to industry shifts through its strong financial foundation and infrastructure.
• The company continues to focus on high-quality, cost-effective patient care to differentiate itself in a competitive market.

Industry Context

StockSavvy.ai notes that Encompass Health continues to outperform in the post-acute care sector by leveraging its scale and operational efficiency, despite broader industry headwinds related to Medicare reimbursement and labor costs.

Comparison to Industry Standards

• Maintains a leading position as the largest owner/operator of inpatient rehabilitation hospitals in the U.S.
• Demonstrates superior capital structure management compared to smaller regional post-acute providers.

Corporate Governance

Legal Proceedings

• Ongoing litigation and regulatory audits are standard in the healthcare industry.
• Settled claims against former executives of the spun-off home health and hospice business.

Related Party Transactions

• Sale of 50% membership interest in Gamma Knife Center at Barnes-Jewish Hospital to joint venture partner.

Stakeholder Impact

• Shareholders benefit from continued dividends and share repurchases.
• Employees and patients benefit from ongoing hospital expansions and capacity additions.

Next Steps

• Continue development of new de novo hospitals scheduled for 2026 and 2027.
• Monitor and respond to the 2027 Proposed IRF Rule from CMS.
• Continue share repurchases and dividend payments as authorized by the board.

Key Dates

Recommendation

The company demonstrates consistent growth, strong cash flow generation, and a disciplined approach to capital allocation, making it an attractive long-term hold for institutional investors.

Keywords

Encompass Health, Inpatient Rehabilitation, Healthcare, Medicare, EHC, Hospital Operations, Financial Results